JB Pharma reported a 16% YoY increase in Q2FY25 net profit to Rs 175 crore, driven by 22% growth in domestic business. Revenues rose 13% to Rs 1,001 crore, while EBITDA grew 13%, maintaining margins at 28.4%.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
